Walgreens’ (WBA) in-store naloxone brand will face competition from the likes of Narcan and Opvee from Emergent BioSolutions ...

The drug is called Opvee and was approved by the FDA in May of 2023 and is the first Nalmefene nasal spray to be approved. It is another step further in helping fight overdoses both from addiction ...

To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be available to Americans aged 12 and older with a prescription, the FDA said. "The agency continues to ...

The sheriff’s office and correctional facility will now carry, Opvee, which Broome County Sheriff Fred Akshar has deemed to be a “fentanyl fighter.” Opvee will be carried by deputies and ...

The award from the Biomedical Advanced Research and Development Authority (BARDA) will be used in part to create a stockpile of 200,000 doses of Opvee, the first nalmefene-based nasal spray to be ...

Tallahassee is without a postmaster as mail delivery issues persist and a USPS Office of the Inspector General audit is underway. Both Narcan and Opvee can reverse an opioid overdose in minutes.

PERSERIS Net Revenue: Reported at $11 million, up 38% versus the prior year. OPVEE Net Revenue: Described as modest; full-year guidance of $15 million to $25 million. Adjusted Gross Margin ...

Indivior PLC (LSE/Nasdaq: INDV) today announced results from a pharmacodynamic study demonstrating that OPVEE® rapidly reverses opioid-induced respiratory depression, which is the major cause of ...

The analyst at Craig-Hallum pointed to Indivior's innovative approach and significant growth prospects, particularly from its products Sublocade and Opvee. These products are central to the ...

PERSERIS Net Revenue: Reported at $11 million, up 38% versus the prior year. OPVEE Net Revenue: Described as modest; full-year guidance of $15 million to $25 million. Adjusted Gross Margin: Remained ...